Results 81 to 90 of about 35,947 (209)
Interobserver variation of psoriasis area and severity index in a clinical setting
Background: Severity scoring systems are important parameters in assessing the severity of a disease aiding in categorization of disease and its prompt treatment. However, reliability of these scoring systems and inter-observer variation is a concern.
Neema Sandra Dias +2 more
openaire +2 more sources
Psoriasis is one of the most prevalent chronic inflammatory skin diseases. The severity of its clinical manifestations can vary greatly. Objective assessment of psoriasis severity is required to select an adequate therapy. One of the simplest and most consistent methods used to determine psoriasis severity is to calculate the PASI (Psoriasis Area and ...
A. A. Kubanov +4 more
openaire +3 more sources
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date. [PDF]
Plaque psoriasis is an immune-mediated skin disease that affects roughly 3% of adults in the United States. Advances over the past 20 years in understanding the immune-mediated pathophysiology of psoriasis have led to the development of targeted biologic
Beck, Kristen M +3 more
core
Increased cysteinyldopa plasma levels hint to melanocyte as stress sensor in psoriasis [PDF]
The possible role of melanocyte as a modulator of the inflammation and keratinocyte hyperproliferation in psoriasis has been hypothesised but never demonstrated on experimental basis.
Ayala F +5 more
core +1 more source
Introduction Psoriasis is a chronic immune-mediated skin condition that has a substantial impact on patients’ quality of life. The Saudi Arabia Psoriasis Registry (PSORSA) was established to address long-term real-world data (RWD) on systemic and ...
Mohammed Ibrahim Fatani +6 more
doaj +1 more source
Background: Psoriasis vulgaris is a common chronic dermatological disease that has a negative impact on the psychological status and the social interaction of the patient.
Ali Al Raddadi +6 more
doaj +1 more source
Cost effectiveness of treatments of psoriasis with a PASI 75 and one period of 12 weeks [PDF]
Fundamentos: Los nuevos tratamientos biológicos, si bien mejoran la calidad de vida del paciente, incrementan los costes exponencialmente en relación al resto de tratamientos.
Alfageme Roldán, Fernando +3 more
core +1 more source
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: systematic review, statistical modelling and survey. [PDF]
© Queen’s Printer and Controller of HMSO 2014Background: The National Institute for Health and Care Excellence recommends the use of generic preference-based measures (GPBMs) of health for its Health Technology Assessments (HTAs). However, these data may
Brazier, J +11 more
core +4 more sources
Background: Psoriasis is a chronic inflammatory skin disease linked to systemic comorbidities, including metabolic, cardiovascular, and autoimmune disorders. Thyroid dysfunction, particularly hypothyroidism, has been observed in patients with moderate-to-
Ricardo Ruiz-Villaverde +5 more
doaj +1 more source
C-Reactive Protein in Various Degrees Severity of Psoriasis Vulgaris
Background: Psoriasis vulgaris is an inflammatory, chronic, recurrent, and, non-contangious skin disease. The severity grade of psoriasis is measured with psoriasis area and severity index (PASI) score.
Lita Setyowatie +2 more
doaj +1 more source

